191 related articles for article (PubMed ID: 20029154)
1. Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children.
Kaul S; Uparkar M; Mody K; Walinjkar J; Kothari M; Natarajan S
Indian J Ophthalmol; 2010; 58(1):76-8. PubMed ID: 20029154
[TBL] [Abstract][Full Text] [Related]
2. Resolution of macular edema in Coats' disease with intravitreal bevacizumab.
Entezari M; Ramezani A; Safavizadeh L; Bassirnia N
Indian J Ophthalmol; 2010; 58(1):80-2. PubMed ID: 20029156
[TBL] [Abstract][Full Text] [Related]
3. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.
He YG; Wang H; Zhao B; Lee J; Bahl D; McCluskey J
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1519-21. PubMed ID: 20379736
[TBL] [Abstract][Full Text] [Related]
4. Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.
Jun JH; Kim YC; Kim KS
Korean J Ophthalmol; 2008 Sep; 22(3):190-3. PubMed ID: 18784449
[TBL] [Abstract][Full Text] [Related]
5. Combined intravitreal bevacizumab and argon laser treatment for Coats' disease.
Cackett P; Wong D; Cheung CM
Acta Ophthalmol; 2010 Mar; 88(2):e48-9. PubMed ID: 19500078
[No Abstract] [Full Text] [Related]
6. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
7. Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation.
Stergiou PK; Symeonidis C; Dimitrakos SA
Acta Ophthalmol; 2009 Sep; 87(6):687-8. PubMed ID: 18976310
[No Abstract] [Full Text] [Related]
8. Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis.
Windisch R; Kozousek V
Can J Ophthalmol; 2008 Aug; 43(4):489-90. PubMed ID: 18711474
[No Abstract] [Full Text] [Related]
9. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
10. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
Raoof N; Quhill F
Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
[TBL] [Abstract][Full Text] [Related]
11. The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.
Zheng XX; Jiang YR
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):35-42. PubMed ID: 23873253
[TBL] [Abstract][Full Text] [Related]
12. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
Charbel Issa P; Holz FG; Scholl HP
Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
[TBL] [Abstract][Full Text] [Related]
13. Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium.
Sun Y; Jain A; Moshfeghi DM
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1387-8. PubMed ID: 17342503
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
[TBL] [Abstract][Full Text] [Related]
15. Juxtafoveal telangiectasias.
Querques G; Delle Noci N
Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
[No Abstract] [Full Text] [Related]
16. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
[TBL] [Abstract][Full Text] [Related]
17. Role of intravitreal bevacizumab in adult onset Coats' disease.
Goel N; Kumar V; Seth A; Raina UK; Ghosh B
Int Ophthalmol; 2011 Jun; 31(3):183-90. PubMed ID: 21437759
[TBL] [Abstract][Full Text] [Related]
18. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Rishi P; Rishi E; Shroff D
Indian J Ophthalmol; 2009; 57(3):241-2. PubMed ID: 19384026
[No Abstract] [Full Text] [Related]
19. Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease.
Cakir M; Cekiç O; Yilmaz OF
J AAPOS; 2008 Jun; 12(3):309-11. PubMed ID: 18589387
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal Bevacizumab as an adjunct to laser in the management of adult onset Coats' disease.
Goel N; Kumar V
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1861-2. PubMed ID: 27234923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
